Real-time enrollment status for this advanced cancer clinical trial
Current Status
Terminated
Checked: April 18, 2026 at 12:23 AM UTC
| NCT Number | NCT06287463 |
| Recruiting Status | Terminated |
| Condition | Advanced Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 140 participants |
| Active Locations | 9 sites in the US |
| Sponsor | Deciphera Pharmaceuticals, LLC |
| Last Updated on CT.gov | March 5, 2026 (Mar 5, 2026) |
As of April 18, 2026: Clinical trial NCT06287463 is currently terminated participants. This clinical trial study for advanced cancer is not currently accepting new participants at 9 locations across the United States. The study is sponsored by Deciphera Pharmaceuticals, LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06287463 is currently terminated. The study may resume recruiting in the future.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06287463 was last updated Mar 5, 2026 (March 5, 2026). HelloStudys verifies this status automatically.